FDA approves new pain medicine

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...